ADVISORY ON CONCERN FOLLOWING RELEASE OF DATA ON REDUCED NEUTRALISING ANTIBODY ACTIVITY IN SERA FROM PFIZER VACCINEES 2021-07-26T13:56:33+02:00Feb 28th, 2021|MAC Advisories| click on the link below to download the pdf ADVISORY – Pfizer Vaccine_V2 facebooktwitterlinkedinwhatsappEmail Related Posts Background document supporting the recommendations for selective vaccination of children 12-17 years old with COVID-19 vaccines in South Africa. BACKGROUND DOCUMENT MANDATORY COVID-19 VACCINATIONS IN CERTAIN WORKPLACES MAC Advisory: MITIGATING THE IMPACT OF COVID-19 DURING THE MUNICIPAL ELECTIONS – UPDATE ADVISORY ON BOOSTER JOHNSON & JOHNSON VACCINE FOR HEALTHCARE WORKERS – V2
